Paper7208525
Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay.
Alberts DS and 1 other. Prog Clin Biol Res, 1980. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay. Papers, record 7208525. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7208525
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Cells, Cultured | |
| Clone Cells | |
| Dose-Response Relationship, Drug | |
| Humans | |
| Neoplasms |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23136592 | Selection of chemotherapy for glioblastoma expressing O(6)-methylguanine-DNA methyltransferase. | Exp Ther Med | 2010 | https://conductscience.org/library/papers/23136592 | PubMed |
| 14612899 | Promising survival for patients with glioblastoma multiforme treated with individualised chemotherapy based on in vitro drug sensitivity testing. | Br J Cancer | 2003 | https://conductscience.org/library/papers/14612899 | PubMed |
| 8944334 | Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay. | Breast Cancer Res Treat | 1996 | https://conductscience.org/library/papers/8944334 | PubMed |
| 8913836 | Efficacy of 5'-nor-anhydrovinblastine (vinorelbine), against freshly explanted clonogenic human tumor cells in vitro. | Invest New Drugs | 1996 | https://conductscience.org/library/papers/8913836 | PubMed |
| 8272413 | Histocultures of patient head and neck tumors for pharmacodynamics studies. | Pharm Res | 1993 | https://conductscience.org/library/papers/8272413 | PubMed |
| 8018519 | Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours. | Br J Cancer | 1994 | https://conductscience.org/library/papers/8018519 | PubMed |
| 7907234 | Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-cell viability assay. | Breast Cancer Res Treat | 1993 | https://conductscience.org/library/papers/7907234 | PubMed |
| 7749161 | In vitro activity of taxol and taxotere in comparison with doxorubicin and cisplatin on primary cell cultures of human breast cancers. | Breast Cancer Res Treat | 1995 | https://conductscience.org/library/papers/7749161 | PubMed |
| 7499107 | Adenocarcinoma of unknown primary: retrospective analysis of chemosensitivity of 313 freshly explanted tumors in a tumor cloning system. | Invest New Drugs | 1995 | https://conductscience.org/library/papers/7499107 | PubMed |
| 6873970 | Establishment, characterization, and response to cytotoxic and radiation treatment of three human melanoma cell lines. | In Vitro | 1983 | https://conductscience.org/library/papers/6873970 | PubMed |
| 6687222 | Activity of 4'-0-tetrahydropyranyladriamycin hydrochloride (THP-ADM) in a human tumor cloning system. | Invest New Drugs | 1983 | https://conductscience.org/library/papers/6687222 | PubMed |
| 6540761 | Identification of synergistic combinations of spirogermanium with 5-fluorouracil or cisplatin using a range of human tumour cell lines in vitro. | Invest New Drugs | 1984 | https://conductscience.org/library/papers/6540761 | PubMed |
| 6381659 | Morphologic, cytochemical and neurochemical characterization of the human medulloblastoma cell line TE671. | J Neurooncol | 1984 | https://conductscience.org/library/papers/6381659 | PubMed |
| 6380788 | Cell survival in four ovarian carcinoma xenografts following in vitro exposure to melphalan, cisplatin and cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA,JM8). | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6380788 | PubMed |
| 6357259 | Hormone supplemented media for cloning human breast cancer: increased colony formation without alteration of chemosensitivity. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6357259 | PubMed |
| 6297528 | Assay of anticancer drugs in tissue culture: cell cultures of biopsies from human astrocytoma. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6297528 | PubMed |
| 6190492 | An assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6190492 | PubMed |
| 4039488 | Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line. | Urol Res | 1985 | https://conductscience.org/library/papers/4039488 | PubMed |
| 3971476 | Comparison of the cellular pharmacology of doxorubicin in resistant and sensitive models of pancreatic cancer. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/3971476 | PubMed |
| 3900924 | Predictive testing in cancer chemotherapy. II. In vitro. | Pharm Weekbl Sci | 1985 | https://conductscience.org/library/papers/3900924 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7208525
GET https://conductscience.org/api/papers/v1/7208525/cited_by?page=2